BIOMAT Database Logo BIOMAT Database Logo

Increased plasma alpha (1 --> 3)-L-fucosyltransferase activities in patients with hepatocellular carcinoma. 1995

T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
Third Department of Internal Medicine, Hyogo College of Medicine, Mukogawa-Cho Nishinomiya, Japan.

Alpha (1 --> 3)-L-fucosyltransferase (alpha 1,3FT) activity was determined in plasma of patients with chronic liver diseases, namely, chronic hepatitis (CH), liver cirrhosis (LC) and hepatocellular carcinoma (HCC), The plasma alpha 1,3FT activity was significantly higher (p < 0.01) in chronic liver diseases than that in normal controls. The enzyme activity in plasma of patients with HCC was also significantly higher than that in LC (p < 0.05) or that in CH (p < 0.01). However, no significant difference was observed in the enzyme activity between LC and CH. Plasma alpha 1,3FT activity in patients with HCC was not significantly changed before and after transcatheter arterial embolization. In addition, the enzyme activity in the homogenate of the cirrhotic liver tissue was higher than that in the preparation of the hepatoma tissue in the same patient. These results suggest that the increased plasma alpha 1,3FT activity in patients with HCC reflects mainly the enzyme activity of cirrhotic liver tissue, not that of hepatoma tissue. The significance of the elevated levels of plasma alpha 1,3FT and its decreased hepatoma tissue activity in patients with HCC, compared with that in LC, remains to be clarified.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002240 Carbohydrate Sequence The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS. Carbohydrate Sequences,Sequence, Carbohydrate,Sequences, Carbohydrate

Related Publications

T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
Altered plasma and tissue fucosyltransferase activities in hepatocellular carcinoma.
June 1990, Biochemical Society transactions,
T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
Identification and characterization of two distinct alpha-(1-3)-L-fucosyltransferase activities in human colon carcinoma.
November 1990, Cancer research,
T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
Plasma fucosyltransferase activity in patients with hepatocellular carcinoma, with special reference to correlation with fucosylated species of alpha-fetoprotein.
June 2000, Journal of hepatology,
T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
Novel method for quantifying alpha(1----3)-L-fucosyltransferase activity in serum.
December 1991, Clinical chemistry,
T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
Characterization of plasma alpha(1----3)-L-fucosyltransferase from an ovarian cancer patient with the aid of synthetic substrates.
January 1988, Indian journal of biochemistry & biophysics,
T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
[Clinical significance of alpha(1----3)-L-fucosyltransferase activities in sera from patients with malignant diseases with a special reference to a potential tumor marker].
May 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
Elevated activities of blood group Le gene dependent alpha(1----3)-L-fucosyltransferase in human saliva of Lewis negative patients with epithelial ovarian cancer.
August 1986, Cancer letters,
T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
Cancer-associated elevation of alpha(1----3)-L-fucosyltransferase activity in human serum.
August 1988, Cancer,
T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
Tumor-related elevation of serum (alpha 1----3)-L-fucosyltransferase activity in gastric cancer.
January 1989, Journal of cancer research and clinical oncology,
T Hada, and K Fukui, and M Ohno, and S Akamatsu, and S Yazawa, and K Enomoto, and K Yamaguchi, and Y Matsuda, and Y Amuro, and N Yamanaka
Serum sialyltransferase and fucosyltransferase activities in patients with bronchial carcinoma.
November 1983, Cancer,
Copied contents to your clipboard!